VOYA Investment Management’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.91M Buy
199,390
+69,153
+53% +$1.23M ﹤0.01% 1085
2026
Q1
$2.47M Buy
130,237
+17,800
+16% +$288K ﹤0.01% 1091
2025
Q4
$1.97M Sell
112,437
-90,181
-45% -$1.7M ﹤0.01% 1221
2025
Q3
$4.19M Sell
202,618
-3,081
-1% -$74.7K ﹤0.01% 939
2025
Q2
$4.38M Sell
205,699
-16,652
-7% -$380K ﹤0.01% 1006
2025
Q1
$4.29M Sell
222,351
-34,041
-13% -$683K ﹤0.01% 1022
2024
Q4
$4.58M Sell
256,392
-1,139
-0.4% -$22.1K ﹤0.01% 1011
2024
Q3
$5.64M Buy
257,531
+485
+0.2% +$6.78K 0.01% 963
2024
Q2
$2M Buy
257,046
+217,580
+551% +$1.18M ﹤0.01% 1317
2024
Q1
$163K Sell
39,466
-8,567
-18% -$34.1K ﹤0.01% 2517
2023
Q4
$125K Buy
48,033
+1,729
+4% +$3.56K ﹤0.01% 2701
2023
Q3
$86.6K Hold
46,304
– – ﹤0.01% 2764
2023
Q2
$116K Buy
+46,304
New +$84.5K ﹤0.01% 2745
2022
Q2
– Sell
-10,629
Closed -$26K – 2879
2022
Q1
$26K Hold
10,629
– – ﹤0.01% 2640
2021
Q4
$29K Sell
10,629
-496
-4% -$2.38K ﹤0.01% 2770
2021
Q3
$56K Sell
11,125
-1,766
-14% -$12.7K ﹤0.01% 2795
2021
Q2
$96K Buy
+12,891
New +$84.6K ﹤0.01% 2778

Other funds holding SMMT

VOYA Investment Management's SMMT Position: Q2 2026 in Review

VOYA Investment Management increased its Summit Therapeutics (SMMT) stake by 53% in Q2 2026, buying an estimated $1.23M and bringing the position to 199,390 shares worth $2.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1085.

VOYA Investment Management first reported a position in SMMT in Q2 2021 and has held it in 17 quarters since. The position peaked at $5.64M in Q3 2024. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • VOYA Investment Management held 199,390 shares of Summit Therapeutics worth $2.91M as of Q2 2026.
  • VOYA Investment Management bought 69,153 Summit Therapeutics shares in Q2 2026, an estimated $1.23M.
  • Summit Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1085 holding.
  • VOYA Investment Management first reported a position in Summit Therapeutics in Q2 2021 and has held it in 17 quarters since.
  • VOYA Investment Management's Summit Therapeutics position peaked at $5.64M in Q3 2024.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.